PURPOSE:Telomere length plays an important role in the maintenance of chromosomal stability and in tumorigenesis. We hypothesized that telomere length in peripheral WBC DNA obtained from healthy individuals would be a predictor of future risk of developing non-Hodgkin lymphoma. EXPERIMENTAL DESIGN: Using a new assay to measure relative telomere length, monochrome multiplex quantitative PCR, which strongly correlates with telomere length measured by Southern blot (Spearman r = 0.91, P < 0.0001) and has high precision (coefficient of variation = 7%), we compared telomere length in peripheral WBC DNA in 107 incident male non-Hodgkin lymphoma cases and 107 matched controls within the prospective Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study cohort. RESULTS: Median (10th, 90th percentile) telomere length was 1.10 (0.79, 1.43) in cases and 1.02 (0.78, 1.26) in controls (P = 0.0017, Wilcoxon sign test). There was a strong dose-response relationship between quartiles of telomere length and risk of non-Hodgkin lymphoma overall [odds ratios (95% confidence intervals) by quartile: 1.0; 1.1 (0.4-2.7); 1.8 (0.7-4.9); and 3.6 (1.4-8.9); P trend = 0.003], and this association was similar across the most common non-Hodgkin lymphoma subtypes present in this study. CONCLUSION: These results suggest that longer telomere length may be a potential predictor for future risk of non-Hodgkin lymphoma.
RCT Entities:
PURPOSE: Telomere length plays an important role in the maintenance of chromosomal stability and in tumorigenesis. We hypothesized that telomere length in peripheral WBC DNA obtained from healthy individuals would be a predictor of future risk of developing non-Hodgkin lymphoma. EXPERIMENTAL DESIGN: Using a new assay to measure relative telomere length, monochrome multiplex quantitative PCR, which strongly correlates with telomere length measured by Southern blot (Spearman r = 0.91, P < 0.0001) and has high precision (coefficient of variation = 7%), we compared telomere length in peripheral WBC DNA in 107 incident male non-Hodgkin lymphoma cases and 107 matched controls within the prospective Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study cohort. RESULTS: Median (10th, 90th percentile) telomere length was 1.10 (0.79, 1.43) in cases and 1.02 (0.78, 1.26) in controls (P = 0.0017, Wilcoxon sign test). There was a strong dose-response relationship between quartiles of telomere length and risk of non-Hodgkin lymphoma overall [odds ratios (95% confidence intervals) by quartile: 1.0; 1.1 (0.4-2.7); 1.8 (0.7-4.9); and 3.6 (1.4-8.9); P trend = 0.003], and this association was similar across the most common non-Hodgkin lymphoma subtypes present in this study. CONCLUSION: These results suggest that longer telomere length may be a potential predictor for future risk of non-Hodgkin lymphoma.
Authors: Jin Sung Jang; Yi Young Choi; Won Kee Lee; Jin Eun Choi; Sung Ick Cha; Yeon Jae Kim; Chang Ho Kim; Sin Kam; Tae Hoon Jung; Jae Yong Park Journal: Cancer Sci Date: 2008-04-29 Impact factor: 6.716
Authors: Jiali Han; Abrar A Qureshi; Jennifer Prescott; Qun Guo; Li Ye; David J Hunter; Immaculata De Vivo Journal: J Invest Dermatol Date: 2008-07-31 Impact factor: 8.551
Authors: Ulrika Svenson; Katarina Nordfjäll; Birgitta Stegmayr; Jonas Manjer; Peter Nilsson; Björn Tavelin; Roger Henriksson; Per Lenner; Göran Roos Journal: Cancer Res Date: 2008-05-15 Impact factor: 12.701
Authors: Xifeng Wu; Christopher I Amos; Yong Zhu; Hua Zhao; Barton H Grossman; Jerry W Shay; Sherry Luo; Waun Ki Hong; Margaret R Spitz Journal: J Natl Cancer Inst Date: 2003-08-20 Impact factor: 13.506
Authors: Yani Lu; Huiyan Ma; Jane Sullivan-Halley; Katherine D Henderson; Ellen T Chang; Christina A Clarke; Susan L Neuhausen; Dee W West; Leslie Bernstein; Sophia S Wang Journal: Am J Epidemiol Date: 2010-05-27 Impact factor: 4.897
Authors: Xiaoying Fu; Shaogui Wan; Hie-Won Hann; Ronald E Myers; Richard S Hann; Jennifer Au; Bicui Chen; Jinliang Xing; Hushan Yang Journal: Eur J Cancer Date: 2012-03-21 Impact factor: 9.162
Authors: Gabriella M Anic; Vernon K Sondak; Jane L Messina; Neil A Fenske; Jonathan S Zager; Basil S Cherpelis; Ji-Hyun Lee; William J Fulp; Pearlie K Epling-Burnette; Jong Y Park; Dana E Rollison Journal: Cancer Epidemiol Date: 2013-03-21 Impact factor: 2.984